Uluslararası hakemli dergilerde yayımlanan makaleler
A1. Ismet A, Irfan K, Emin K, All EM, Ramazan U, Mustafa B, Onur O. Splenectomy Results in Patients with Idiopathic Thrombocytopenic Purpura: 10 Years of Experience in Turgut Ozal Medical Center. Clin.Lab.Haem. 2004;26(3):211-214 DOI: 10.1111/j.1365-2257.2004.00602.x
A2. Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyol O, Erkurt MA. Oxidant/antioxidant Parameters and Their Relationship with Medical Treatment in Multiple Myeloma. Cell Bıochemistry and Function. 2005; 23(1):47-50 DOİ:10.1111/j.1365-2257.2004.00602.x
A3. Kuku I, Aydogdu I, Kaya E, Ali Erkurt M, Dikilitas M, Baydar M, Yildiz R.The early and long-term results of oral high-dose methylprednisolone treatment in adult patients with idiopathic thrombocytopenic purpura: Letter to the Editor. Eur J Haematol. 2005;74(3):271-2. DOI: 10.1111/j.1600-0609.2004.00378.x
A4. Aydogdu I, Erkurt AM, Kaya E, Kuku I. Images in Haematology Bone relapse in a patient with acute lymphoblastic leukaemia. Br J Haematol. 2005;129(2):163. DOİ: 10.1111/j.1365-2141.2005.05390.x
A5. Kuku I, Bayraktar MR, Kaya E, Erkurt MA, Bayraktar N, Cikim K, Aydogdu I. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma. Mediators Inflamm. 2005;14(3):171-4. DOİ: 10.1155/MI.2005.171
A6. Kaya E, Keskin L, Aydogdu I, Kuku I, Bayraktar N, Erkut MA. Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma. J Int Med Res. 2005; 33(6):687-92. DOI: 10.1177/147323000503300611
A7. Aydogdu İ, Kaya E, Kuku İ, Erkurt MA, Görgel A, Ozhan O. A rare syndrome that can easily be missed: May-Hegglin anomaly. Case Report. Turk J Hematol 2005; 22(2): 91-93.
A8. Erkurt MA, Kaya E, Baran M, Yitmen E, Şenel S, Kuku İ, Aydoğdu İ. Rapid progression of acquired amegakaryocytic thrombocytopenia to myelodysplastic syndrome: case report. Turk J Hematol 2005; 22(4): 205- 208.
A9. Senel S, Kaya E, Aydogdu I, Erkurt MA, Kuku I. Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. Rheumatol Int. 2006;11:1-5 DOI 10.1007/s00296-005-0100-5
A10. Aydogdu I, Erkurt MA, Ozhan O, Kaya E, Kuku I, Yitmen E, Aydin NE. Reversible Bone Marrow Necrosis in a Patient Due to Overdosage of Diclofenac Sodium. Letters and Correspondence. Am J Hematol. 2006; 20;81(4):298-305 DOI: 10.1002/ajh.20536
A11. Altuntas F, Aydogdu I, Kabukcu S, Kocyigit I, Cikim K, Sari I, Erkut MA, Eser B, Ozturk A, Kaya E, Cetin M, Keskin A, Unal A. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study. Transfusion And Apheresis Science 2007; 36(1):57-67. doi:10.1016/j.transci.2006.05.014
A12. Aydogdu I, Kaya E, Karadag N, Erkurt M, Kuku I, Ozhan O, Oner RI, Bayindir Y. Transfusion-Associated Graft-Versus-Host Disease in Patients with and without Immunodeficiency: Report of Six Cases. Transfus Med Hemother. 2007;34:79-82. DOI:10.1159/000098105
A13. Kaya E, Erkurt MA, Aydogdu I, Kuku I, Ozhan O, Oner RI, Ulutas O. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia. Med Princ Pract. 2007;16(2):100-6.
A14. Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacıoglu SK, Ismailogulları S, Turgut N, Erkurt MA, Sari I, Oztekin M, Solmaz M, Eser B, Ozdemir Ersoy A, Unal A, Cetin M. Therapeutic plasma exchange in patients With neurologic diseases: Retrospective multicenter study. Transfus Apher Sci. 2008;38(2):109-115. doi:10.1016/j.transci.2007.11.002
A15. Erkurt MA, Aydogdu I, Dikilitaş M, Kuku I, Kaya E, Bayraktar N, Ozhan O, Ozkan I, Sönmez A. Effects of Cyanocobalamin on Immunity in Patients with Pernicious Anemia. Med Princ Pract 2008;17(2):131-135. DOI:10.1159/000098360
A16. Erkurt MA, Sari I, Gül HC, Coskun O, Eyigün CP, Beyan C. The first documented case of brucellosis manifested with pancytopenia and capillary leak syndrome. Intern Med. 2008;47(9):863-5. (DOI: 10.2169/internalmedicine.47.0834)
A17. Erkurt MA, Aydogdu A, Kuku I, Kaya E, Ozhan O. Anticancer Drug Induced Glomerular Dysfunction. World Journal Of Medical Sciences. 2008;3(1):5- 9.
A18. Bayraktar N, Erkurt MA, Aydoğdu İ, Başaran Y. The levels of nitric oxide in beta-thalassemia minor. Turk J Hematol 2008;25:187-9.
A19. Erkurt MA, Aydogdu I, Kuku I, Kaya E, Basaran Y. Nodular melanoma presenting with rapid progression and widespread metastases: a case report Journal of Medical Case Reports. 2009, 6;3(1):50. doi:10.1186/1752-1947-3-50
A20. Ates F, Erkurt MA, Karincaoglu M, Aladag M, Aydogdu I. Prevalence of Gallstones in Patients with Chronic Myelocytic Leukemia. Med Princ Pract. 2009;18(3):175-9. (DOI:10.1159/000204346)
A21. Erkurt MA, Aydogdu I, Kuku I, Kaya, Mizrak B, Basaran Y. A multicentric, hyaline vascular variant of castleman’s disease associated with b cell lymphoma: a case report. Cases Journal. 2009; doi: 10.4076/1757-1626-2- 8183.
A22. Sari I, Erkurt MA, Ifran A, Kaptan K, Beyan C. Multiple myeloma presenting with acquired factor VIII inhibitor. Int J Hematol. 2009; 90(2):166-9. 10.1007/s12185-009-0363-9.
A23. Erkurt MA, Aydogdu I, Kuku I, Kaya E, Basaran Y. Clinicopathologic Characteristics and Therapeutic Outcomes of Primary Gastrointestinal Non- Hodgkin's Lymphomas: 10 Years of Experience from a Single Centre in Eastern Anatolia. Med Princ Pract 2009;18:399-406. 10.1159/000226295
A24. Erkurt MA, Aydoğdu İ, Bayraktar N, Kuku İ, Kaya E. The levels of nitric oxide in megaloblastic anemia. Turk J Hematol 2009; 26: 197-200.
A25. Turkmen K, Altintepe L, Guney I, Aydogdu I, Koc O, Erkut MA, Tonbul HZ. Uncontrolled hypertension secondary to leukemic cell infiltration of kidneys in a hemodialysis patient. Int J Nephrol Renovasc Dis. 2010;3:65-8.
A26. Erkurt MA, Aydogdu I, Kuku I, Kaya E, Comert M, Basaran Y. Natriuretic Peptides’ Role in Determining the Chemoterapy-Induced Nephrotoxicitiy and Their Value in Follow-Up. World Nephrol Urol 2011;1:16-22. doi:10.4021/wjnu7e
A27. Erkurt MA, Kaya E, Berber I, Koroglu M, Kuku I. Thrombocytopenia in Adults: Review Article. J Hematol 2012;1(2-3):44-53. doi:10.4021/jh28w
A28. Dal SE, Ersoy Y, Erkurt MA, Yetkin F, Kuzucu C, Akdoğan O. An Uncommon case of acute brucellosis presenting with severe thrombocytopenia. Intern Med. 2012;51(23):3291-3. (DOI: 10.2169/internalmedicine.51.7365)
A29. Erkurt MA, Kuku I, Kaya E, Ozgen U, Berber I, Koroglu M, Ozgül M. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia. Transfus Apher Sci. 2013;48(3):335-9 10.1016/j.transci.2013.04.012
A30. Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, Erkurt MA, Sivgin S, Korkmaz S, Okan V, Doğu MH, Unal A, Cetin M, Altuntaş F, Ilhan O. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis. Transfus Apher Sci. 2013;48(3):349-52 10.1016/j.transci.2013.04.015
A31. Berber I, Erkurt MA, Koroglu M, Kuku I, Kaya E, Bentli R. Burkitt’s lymphoma presenting with rapidly and multi-organ involvement: A case presentation. Case Reports in Clinical Medicine. 2013;2(4):242-245.
A32. Koroglu M, Erkurt MA, Berber I, Kuku I, Kaya E, Ozkahraman A, Aydin NE. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: A case report. Transfus Apher Sci. 2013; 49(2):341-4. doi: 10.1016/j.transci.2013.05.009
A33. Berber I, Erkurt MA, Kuku I, Koroglu M, Kaya E, Unlu S. A Rare Disease in Adult: Langerhans Cell Histiocytosis. World Journal of Oncology. 2013; 4(3): 165-168. doi: 10.4021/wjon663w
A34. Berber I, Koroglu, M, Erkurt MA, Oguz F, Altıntas R, Kaya E, Kuku I, Ulutas O. After allogenic bone marrow transplantation agent of hemorrhagic cystitis: BK virüs. Case Reports in Clinical Medicine. 2013;2(5):298-301.
A35. Erkurt MA, Berber I, Nizam I, Kaya E, Köroglu M, Kuku I, Kalaylı O. Etiologic Evaluation of 1012 Patients Admitted with Thrombocytopenia. British Journal of Medicine & Medical Research 2014;4(1):104-113.
A36. Kaya F, Berber I, Erkurt MA, Aydogdu I, Reisli I. Roles of CD5+, CD19+, CD41a+, CD55+ and CD59+ in Chronic Immune Thrombocytopenic Purpura (ITP). British Journal of Medicine & Medical Research 2014;4(2):660- 670.
A37. Bentli R, Berber I, Erkurt MA, Aydogdu I, Gündüz E, Nizam I, Kaya E, Kuku I, Köroglu M. Clinicopathological Characteristics of Pernicious Anemia: A Study of 300 Patients in Turkey. British Journal of Medicine & Medical Research 2014;4(3):807-815.
A38. Berber I, Erkurt MA, Köroglu M, Bentli R, Nizam I, Kaya E, Kuku I, Sezgin S. Decitabine Induced Localized Maculopapular Eruption. British Journal of Medicine & Medical Research 2014;4(4):1002-1007.
A39. Berber I, Bentli R, Erkurt MA, Ulutas O, Ediz C, Nizam I, Berber NK, Unlu S, Köroglu R, Köroglu M, Akpolat N. Pulmonary Embolism as the Initial Presentation of Testicular Carcinoma. Case Reports in Oncological Medicine Volume 2013, Article ID 264569, 4 pages. Doi: 10.1155/2013/264569
A40. Nizam I, Erkurt MA, Berber I, Kaya E, Kuku I. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia. American Journal of Medical Case Reports 2014;2(1):19-21. Doi: 10.12691/ajmcr-2-1-6
A41. Berber I, Erkurt MA, Kuku I, Kaya E, Kutlu R, Köroglu M, Yiğit A, Unlü S. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula. Med Princ Pract 2014; 23(4):380-3.
A42. Erkurt MA, Berber I, Kuku I, Kaya E, Nizam I. Donor Selection in Allogeneic Stem Cell Transplantation. American Journal of Clinical Medicine Research. 2014;2(1): 32-35. Doi:10.12691/ajcmr-2-1-8
A43. Nizam I, Erkurt MA, Berber I, Kaya E, Kuku I, Köroglu M. Aggressive Progression of Mantle Cell Lymphoma: A Case Report. American Journal of Medical Case Reports 2014;2(1):30-31. Doi: 10.12691/ajmcr-2-1-10
A44. Berber I, Erkurt MA, Kuku I, Kaya E, Köroglu M, Nizam I, Gül M, Bentli R. Hermansky-Pudlak Syndrome: A Case Report. Case Reports in Hematology. Volume 2014, Article ID 249195, 3 pages. Doi: 10.1155/2014/249195
A45. Yagar Y, Erkurt MA, Berber I, Nizam I, Köroglu M, Berktas HB, Selcuk EB, Kaya E, Kuku I. Acute Myeloid Leukemia: Significance of the Skin Test. American Journal of Medical Case Reports 2014;2(3):55-56. DOI:10.12691/ajmcr-2-3-4.
A46. Berktaş B, Erkurt MA, Berber I, Nizam I, Köroglu M, Selcuk EB, Yagar Y, Kaya E, Kuku I. Atypical Presentation of Plasmacytoma. American Journal of Medical Case Reports 2014;2(4):82-83. DOI:10.12691/ajmcr-2- 4-3
A47. Berber I, Erkurt MA, Yararbas, K, Köroglu M, Nizam I, Berktas B, Selcuk EB, Kuku I, Kaya E. As a Rare Disease Bernard–Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura: A Case Report. American Journal of Medical Case Reports 2014;2(5):102-106. DOI:10.12691/ajmcr-2-5-3.
A48. Berber I, Diri H, Erkurt MA, Aydogdu I, Kaya E, Kuku I. Evaluation of Ferric and Ferrous Iron Therapies in Women with Iron Deficiency Anaemia. Advances in Hematology Volume 2014, Article ID 297057, 6 pages http://dx.doi.org/10.1155/2014/297057.
A49. Berber I, Erkurt MA, Yetkin F, Kuku I, Kaya E, Bodakçı E, Köroglu M, Nizam I. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation: Review Article. American Journal of Medical Sciences And Medicine 2014;2(5):85-88. doi: 10.12691/ajmsm-2-5-1
A50. Berber I, Erkurt MA, Yetkin F, Unlu S, Yilmaz S, Bentli R, Bazna S. A rare disease in the differential diagnosis of acute pancreatitis: acute brucellosis. Intern Med. 2014;53(20):2401-4.
A51. Berber I, Erkurt MA, Kuku I, Kaya E, Unlu S, Ertem K, Nizam I. Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report. Transfus Apher Sci. 2014;51(1):73-6.
A52. A Gorgel, E Kaya, I Berber, I Kuku, E Gunduz, AM Erkurt. Is Imatinib Protective Against to Osteoporosis? - A Comparative Study in Terms of Bone Densitometry on Chronic Myeloid Leukaemia Patients and Healthy Volunteers. DOI: 10.7727/wimj.2015.447.
A53. Erkurt MA, Berber I, Berktas HB, Kuku I, Kaya E, Koroglu M, Nizam I, Bakırhan FA, Ozgul M. A life-saving therapy in Class I HELLP syndrome: Therapeutic Plasma Exchange. Transfus Apher Sci. 2015;52(2):194-198
A54. Berber I, Erkurt MA, Nizam I, Kuku I, Kaya E, Unlu S, Yılmaz M. Diclofenac Related Spontaneous Extensive Ecchymosis and Hematoma Despite Normal Coagulation Parameters. American Journal of Medical Case Reports, 2015; 3(3):82-84.
A55. Berber I, Kuku I, Erkurt MA, Kaya E, Gozukara Bag H, Nizam I, Koroglu M, Ozgul M, Bazna S. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience. Transfus Apher Sci. 2015;;53(2):185-90.
A56. Berber I, Erkurt MA, Kuku I, Kaya E, Bag HG, Nizam I, Koroglu M, Yigit A, Ozgul M. Leukapheresis Treatment in Elderly Acute Leukemia Patients With Hyperleukocytosis: A Single Center Experience. Journal of Clinical Apheresis. 2016;31(1):53-8.
A57. Nizam I, Erkurt MA, Berber I, Kaya E, Kuku I, Köroglu M. Myocardial Infarction in a Splenectomized Patient with Immune Trombocytopenia. American Journal of Medical Case Reports, 2015;3(9):301-303.
A58. Berber I, Erkurt MA, Keklik M, Dogu MH, Terzi H, Pala C, Sarı HI, Sencan M, Sıvgın S, Hacıoglu S, Altuntas F, Aydogdu, Ilhan O. Clinical Characteristics, Post-Treatment Assessment And Prognostic Factors Affecting Patient Survival of Patients at 65 Years Of Age Or Older With Hodgkin Lymphoma: A Retrospective Multicenter Study From Turkey. Acta Medica Mediterranea, 2015, 31: 907-914.
A59. Nizam I, Erkurt MA, Berber I, Koroglu M, Kaya E, Kuku I, Karadag N. Carcinoma Causing Thrombotic Thrombocytopenic Purpura and Myelonecrosis: A Very Rare Event. American Journal of Medical Case Reports, 2015; 3(11): 372-373.
A60. Berber I, Erkurt MA, Nizam I, Koroglu M, Kaya e, Kuku I, Bag HG. Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience. Int JClin Exp Med 2015; 15;8(9):16308-14.
A61. Erkurt MA, Berber I, Tekgunduz E, Dogu MH, Korkmaz S, Demir C, Yilmaz M, Akay OM, Pala C, Bilen Y, Kaya E, Sari I, Sencan M, Kuku I, Altuntas F, Dal MS, Aydogdu I. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study. Transfus Apher Sci. 2016 2016;54(1):80-4 doi: 10.1016/j.transci.2016.01.018
A62. Berber I, Erkurt MA, Kuku I, Kaya E, Gozukara Bag H, Nizam I, Koroglu M, Ozgul M. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience. Transfus Apher Sci. 2016 Feb;54(1):48- 52. doi: 10.1016/j.transci.2016.01.012.
A63. Dogu MH, Kaya AH, Berber I, Sari I, Tekgunduz E, Erkurt MA, Iskender D, Kayikci O, Kuku I, Kaya E, Keskin A, Altuntas F. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation? Transfus Apher Sci. 2016 2016 Feb;54(1):76-9. doi: 10.1016/j.transci.2016.01.017.
A64. Koroglu M, Erkurt MA, Kuku I, Kaya E, Berber I, Nizam I, Yagar Y, Kayis SA. Assessing Safety of Pneumatic Tube System (PTS) for Patients with Very Low Hematologic Parameters. Med Sci Monit. 2016 Apr 20;22:1329-1333. DOI: 10.12659/MSM.898164
A65. Özhan O, Erdem N, Aydoğdu İ, Erkurt MA, Kuku İ.Serum Zinc Levels in Iron Deficiency in Women: A Case Control Study. Turk J Haematol. 2016 Jun 5;33(2):156-8 doi:10.4274/tjh.2015.0206.
A66. Tombak A, Uçar MA, Akdeniz A, Tiftik EN, Gören Şahin D, Akay OM, Yıldırım M, Nevruz O, Kış C, Gürkan E, Solmaz ŞM, Özcan MA, Yıldırım R, Berber İ, Erkurt MA, Fıratlı Tuğlular T, Tarkun P, Yavaşoğlu İ, Doğu MH, Sarı İ, Merter M, Özcan M, Yıldızhan E, Kaynar L, Mehtap Ö, Uysal A, Şahin F, Salim O, Sungur MA. The role of azacitidine in the treatment of elderly patients with AML-results of a retrospective multicenter study. Turk J Haematol. 2016 Dec 1;33(4):273-280. doi: 10.4274/tjh.2015.0203.
A67. Bilgic Y, Akbulut S, Kutlu O, Colak C, Seckin Y, Cağın YF, Harpuluoglu M, Erkurt MA, Yildırım O. Could You Platelet Indices be Prognostic Biyomarkers for Mild or Severe Acut Pancreatitis. Int. J.Clin.Exp.Med. 2016;9(7):13918-13925.
A68. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma. Dogu MH, Çagirgan S, Ocakci S, Kaya AH, Ilkkilic K, Sanli NM, Kahraman S, Eren R, Tekgunduz E, Hacioglu S, Kaynar L, Erkurt MA, Altuntas F. Transfus Apher Sci. 2017 Dec;56(6):814-818. doi: 10.1016/j.transci.2017.11.012. Epub 2017 Nov 8.PMID: 29153347
A69. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA). Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10.PMID: 2915330
A70. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ura l AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Transfus Apher Sci. 2017 Dec;56(6):804-808. doi: 10.1016/j.transci.2017.11.010. Epub 2017 Nov 9. PMID: 29153305
A71. Typical facial appearence of chronic GVHD. Gül HG, Erkurt MA, Kuku I, Kaya E. Tredns in Cancer Research and Chemotherapy. 2018;1(1):1-1
A72. Tekgündüz E, Yılmaz M, Erkurt MA, Kuku I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci. 2018 Feb;57(1):27-30. doi: 10.1016/j.transci.2018.02.012. Epub 2018 Feb 20.PMID: 29503132
A73. Dogu MH, Batgi H, Erkurt MA, Hacioglu S, Tekgunduz E, Kaya E, Iskender D, Eren R, Kuku I, Altuntas F. Stem cell mobilization kinetics in elderly patients with multiple myeloma.Transfus Apher Sci. 2018 Apr;57(2):204-207. doi: 10.1016/j.transci.2018.01.010. Epub 2018 Feb 1.PMID: 29439920
A74. Karaman S, Erkurt MA, Kuku İ, Kaya E, Nuransoy A, Yıldırım HE. Different Presentation of Multiple Myeloma in Bone Marrow Aspiration . Journal of Cancer Science and Clinical Therapeutics 2 (2018): 89-91. doi: 10.26502/JCSCT.5079011
A75. Kaya A, Kaya E, Erkurt MA, Kuku I. Relation of basal vitamin D and parathyroid hormone levels to CD34+cell counts in multiple myeloma and lymphoma patients with stem cell mobilization. 9th International Eurasian Hematology Oncology Congress (EHOC) Leukemia Research (2018) Oct; 73:58
A76. Dogan NY, Erkurt MA, Dogan A, Ekinci O, Kuku I, Kaya E. Clinical and Pathological Characteristics of non-Hodgkin Lymphoma Patients in Eastern Turkey: a Single-Center Study. 9th International Eurasian Hematology Oncology Congress (EHOC) Leukemia Research (2018) Oct; 73:52
A77. Cakan P, Ozgul M, Erkurt MA, Kaya E, Yildiz S, Kuku I. Thrombocytapheresis decreases systolic blood pressure and increases sympatho-vagal balance. 9th International Eurasian Hematology Oncology Congress (EHOC) Leukemia Research (2018) Oct; 73:26
A78. Çiftçiler R, Sevindik ÖG, Tekgündüz AİE, Erkurt MA, Vural F, Turgut B, Kaynar L, Payzın B, Doğu MH, Karakuş V, Altuntaş F, Büyükaşık Y, Demirkan F. Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study. Turk J Haematol. 2019 Aug 2;36(3):169-177. doi: 10.4274/tjh.galenos.2019.2019.0008. Epub 2019 May 27.PMID: 31131598
A79. Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. The Turkish experience with therapeutic plasma exchange: A national survey.Transfus Apher Sci. 2019 Jun;58(3):287-292. doi: 10.1016/j.transci.2019.04.015. Epub 2019 Apr 23.PMID: 31036516
A80. Soyer N,Gunduz M, Tekgunduz E, Deveci B, Ozdogu H, Sahin HH, Turak EE , Okay M, Kuku I, Hindilerden IY, Topcuoglu P, Altuntas F, Karadogan I, Pehlivan M, Unal A, Goker H, Erkurt MA, Besisik SK, Vural F. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG). 45th Annual Meeting of the European-Society-for-Blood-and-MarrowTransplantation (EBMT) Bone Marrow Transplantation 2019 Jul; 54:254-255
A81. Gulbay G, Yesilada E, Erkurt MA, Bag HG, Kuku I, Kaya E. Evaluation of the JAK2 V617F gene mutation in myeloproliferative neoplasms cases: a one-center study from Eastern Anatolia. Turkish Journal of Biochemistry 2019 Feb; 44(4):492-498. doi: 10.1515/tjb-2018-0054
A82. Sarici A, Slocum A, Ulubaba H, Kandemir MH, Erkurt MA, Kaya E, Kuku I. Repeat Ultrasonographic Examinations Reveal Accessory Spleen in a Case with Relapse ITP. Int J Blood Res Disord 2019; 6(1):044 doi: 10.23937/2469-5696/1410044
A83. Demirkan F, Ciftciler R, Sevindik OG, Tekgündüz E, Erkurt MA, Vural F, Turgut B, Kaynar L, Payzin KB, Dogu MH, Karakus V, Altuntas F, Buyukasik Y. Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data. Blood. 2019 Nov; 134(1):5073. doi: 10.1182/blood-2019-126006
A84. Soyer N, Gunduz M, Tekgunduz E, Deveci B, Ozdogu H, Sahin HH, Turak EE, Okay M, Kuku I, Hindilerden IY, Topcuoglu P, Altuntas F, Karadogan I, Pehlivan M, Unal A, Goker H, Erkurt MA, Besısık SK, Vural F; Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG). ThREG (Turkish Hematology Research). Transfus Apher Sci. 2020 Aug;59(4):102827. doi: 10.1016/j.transci.2020.102827. Epub 2020 May 26.PMID: 32522474
A85. Okay M, Aslan T, Özdemir E, Üner A, Sağlam A, Güngör E, Uysal A, Alayvaz Aslan N, Yıldızhan E, Ağıt A, Dal MS, Korkmaz S, Namdaroğlu S, Sivgin S, Akgün Çağlıyan G, Demircioğlu S, Barışta İ, Özhamam E, Vural F, Eser B, Özet G, Yıldırım R, Doğu MH, Berber İ, Erkurt MA, Malkan ÜY, Altuntaş F, Büyükaşık Y. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study. Turk J Haematol. 2020 May 6;37(2):84-90. doi: 10.4274/tjh.galenos.2019.2019.0177. Epub 2019 Oct 21.PMID: 31630512
A86. Erkurt MA, Sarici A, Berber İ, Kuku İ, Kaya E, Özgül M. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia. Transfus Apher Sci. 2020 Oct;59(5):102867. doi: 10.1016/j.transci.2020.102867. Epub 2020 Jun 27.PMID: 32620409
A87. Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. Turkish Ministry of Health, Hematology Scientific Working Group.J Oncol Pharm Pract. 2020 Oct;26(7):1676-1682. doi: 10.1177/1078155220953198. Epub 2020 Aug 27.PMID: 32854573
A88. Yiğenoğlu TN, Ulas T, Dal MS, Korkmaz S, Erkurt MA, Altuntaş F. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption. Transfus Apher Sci. 2020 Aug;59(4):102855. doi: 10.1016/j.transci.2020.102855. Epub 2020 Jun 25.PMID: 32636114
A89. Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, Dal MS, Baştürk A, Namdaroğlu S, Korkmaz S, Ulas T, Dal T, Erkurt MA, Turgut B, Altuntaş F. Convalescent plasma therapy in patients with COVID-19. J Clin Apher. 2020 Aug;35(4):367-373. doi: 10.1002/jca.21806. Epub 2020 Jul 9.PMID: 32643200
A90. Gulbay G, Yesilada E, Erkurt MA, Bag HG. The Evaluation of Common Chromosomal Rearrangements and Their Frequencies in Adult Acute Myeloid Leukemia Cases in Malatya Province of Turkey. East J Med 25(3): 350-355, 2020 doi: 10.5505/ejm.2020.05945
A91. İster E, Serin E, Bayır B, Erkurt MA. The Discharge Related Learning Needs of Hematopoietic Stem Cell Transplant Recipients. Journal of Inonu University Health Services Vocational School. 2020 June; 8(2): 383-396 doi: 10.33715/inonusaglik.705857
A92. Dogan A, Dogan N, Erkurt MA, Ekinci O, Kuku I, Kaya E. Clinical and pathological characteristics of patients with non-Hodgkin lymphoma cases in Eastern Turkey. Cukurova Med J 2020;45(2):533-540. doi: 10.17826/cumj.672199
A93. Altuntas F, Ata N, Yigenoglu T, Basci S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacibekiroglu T, Dogu MH, Berber I, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Akunal A, Birinci S. COVID-19 in hematopoietic cell transplant recipients. Bone Marrow Transplantation (2021) 56:952–955. doi: 10.1038/s41409- 020-01084-x
A94. Sarıcı A, Erkurt MA, Bahçecioğlu ÖF, Biçim S, Berber İ, Gök S, Kaya E, Özgül M, Kuku İ. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma- Single center experience. Transfus Apher Sci. 2021 Aug;60(4):103127. doi:10.1016/j.transci.2021.103127. Epub 2021 Apr 3.PMID: 33863669.
A95. Erkurt MA, Sarici A, Kuku I, Berber I, Kaya E, Bicim S, Karaman S, Ozgul M. The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients. Transfus Apher Sci. 2021 Oct;60(5):103248. doi:10.1016/j.transci.2021.103248. Epub 2021 Aug 14.PMID: 34420883
A96. Goren Sahin D, Akay OM, Keklik M, Okan V, Karakus A, Demir C, Erkurt MA, Ilkkilic K, Yildirim R, Akgun Cagliyan G, Aksu S, Dogu MH, Dal MS, Karakus V, Gemici AI, Terzi H, Kelkitli E, Sivgin S, Unal A, Yilmaz M, Ayyildiz O, Korkmaz S, Eser B, Altuntas F. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience. Ann Hematol. 2021 Jul;100(7):1667-1675. doi: 10.1007/s00277-021-04554-4. Epub 2021 May 14.PMID: 33988739
A97. Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Patients with hematologic cancers are more vulnerable to COVID19 compared to patients with solid cancers. Turkish Ministry of Health, Hematology Scientific Working Group.Intern Emerg Med. 2021 Jun 10:1-5. doi: 10.1007/s11739- 021-02784-y.
A98. Sarıcı A, Erkurt MA, Bahçecioğlu ÖF, Gök S, Kuku İ, Biçim S, Berber İ, Kaya E, Özgül M. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients. Transfus Apher Sci. 2021 Aug;60(4):103159. doi: 10.1016/j.transci.2021.103159. Epub 2021 May 20.PMID: 34034961
A99. Sarici A, Erkurt MA, Kuku I, Gok S, Bahcecioglu OF, Bicim S, Berber I, Kaya E, Ozgul M. Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study. Transfus Apher Sci. 2021 Oct;60(5):103251. doi: 10.1016/j.transci.2021.103251. Epub 2021 Aug 17.PMID: 34419358
A100. Dal MS, Batgi H, Erkurt MA, Hindilerden IY, Kuku I, Kurtoglu E, Kaya E, Besisik SK, Berber I, Nalcaci M, Ulas T, Altuntas F. Extracorporeal photopheresis in steroidrefractory chronic graft-versus-host disease: A retrospective multicenter study. Transfus Apher Sci. 2021 Oct;60(5):103243. doi: 10.1016/j.transci.2021.103243. Epub 2021 Aug 13.PMID: 34420879
A101. Basturk A, Sayin S, Erkurt MA, Sarici A, Ekinci O, Kum A, Berber I, Korkmaz S, Dogan A, Ulas T, Kuku I, Eser B, Altuntas F. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura. Transfus Apher Sci. 2021 Oct;60(5):103246. doi: 10.1016/j.transci.2021.103246. Epub 2021 Aug 13.PMID: 34419359
A102. Batgi H, Dal MS, Erkurt MA, Kuku I, Kurtoglu E, Hindilerden IY, Kaya E, Berber I, Ulas T, Altuntas F. Extracorporeal photopheresis in the treatment of acute graftversus-host disease: A multicenter experience. Transfus Apher Sci. 2021 Oct;60(5):103242. doi: 10.1016/j.transci.2021.103242. Epub 2021 Aug 13.PMID: 34420882
A103. Tanriverdi LH, Sarici A, Erkurt MA, Parlakpinar H. The efficacy of voxelotor, 900 mg in patients with sickle cell anaemia: A meta-analysis of the randomised controlled trials. Int J Clin Pract. 2021 Jun;75(6):e13967. doi: 10.1111/ijcp.13967. Epub 2021 Jan 15.PMID: 33369007
A104. Dal MS, Ata N, Altuntaş F, Başcı S, Yiğenoğlu TN, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Imrat E, Çelik O, Ülgü MM, Birinci Ş. COVID-19 clinical course and blood groups: Turkish population-based study. Turk J Med Sci. 2021 Aug 30;51(4):1659-1664. doi: 10.3906/sag-2101-321.PMID: 33957720
A105. Gul HG, Erkurt MA, Sarici A, Kuku I, Kaya E, Berber I, Merter M, Bicim S, Ozgul M. An innovation in stem cell harvesting: Heparin use. Transfus Apher Sci. 2021 Oct;60(5):103240. doi: 10.1016/j.transci.2021.103240. Epub 2021 Aug 13.PMID: 34404617
A106. Berber I, Korkmaz S, Sarici A, Erkurt MA, Kuku I, Kaya E, Bicim S, Ozgul M. Therapeutic plasma exchange for envenomation: Is it reasonable? Transfus Apher Sci. 2021 Oct;60(5):103241. doi: 10.1016/j.transci.2021.103241. Epub 2021 Aug 13.PMID: 34429240
A107. Aydin K, Korkmaz S, Erkurt MA, Sarici A, Ekinci O, Baysal NA, Berber I, Dogan A, Dal MS, Giden AO, Ulas T, Kuku I, Ozatli D, Eser B, Altuntas F. Apheresis in patients with sepsis: A multicenter retrospective study. Transfus Apher Sci. 2021 Oct;60(5):103239. doi: 10.1016/j.transci.2021.103239. Epub 2021 Aug 13.PMID: 34412948
A108. Yiğenoğlu TN, Başcı S, Şahin D, Ulaş T, Dal MS, Korkmaz S, Hacıbekiroğlu T, Namdaroğlu S, Erkurt MA, Turgut B, Altuntaş F. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Aug 17:103237. doi: 10.1016/j.transci.2021.103237. Online ahead of print.PMID: 34419356
A109. Altuntas F, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Turgut B, Erkurt MA Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.PMID: 33277207
A110. Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Akunal A, Birinci S; COVID-19 in hematopoietic cell transplant recipients. Turkish Ministry of Health, Hematology Scientific Working Group. Bone Marrow Transplant. 2021 Apr;56(4):952-955. doi: 10.1038/s41409-020-01084-x. Epub 2020 Oct 28.PMID: 33110186
A111. Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Kınık K, Haznedaroglu İ, Yılmaz FM, Kılıç İ, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Caglayan M, Celik O. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 Feb;60(1):102955. doi: 10.1016/j.transci.2020.102955. Epub 2020 Sep 19.PMID: 33011076
A112. Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S. The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.PMID: 32776581
A113. Akpinar S, Dogu MH, Celik S, Ekinci O, Hindilerden IY, Dal MS, Davulcu E, Tekinalp A, HindilerdenF, Ozcan B, Hacibekiroglu T, Erkurt MA ... & Altuntas, F. (2021). THE REAL WORLD EXPERIENCE WITH SINGLE AGENT IBRUTINIB IN RELAPSED/REFRACTORY CLL. Clinical Lymphoma Myeloma and Leukemia. 2021 Sep. doi: 10.1016/j.clml.2021.09.010
A114. Dal MS, Merdin A, Erkurt MA, Ekinci Ö, Albayrak M, Hacıoğlu SK, ... & Doǧu MH. Pralatrexate experience in peripheral T-cell lymphoma: a multicenter retrospective study from Turkey. Journal of B.U.ON. 2021; 26(4): 1536–1539.
A115. Nizam ı, Erkurt MA, Berber I, Kaya E, Kuku I, Koroglu M. Myocardial Infarction in a Splenectomized Patient with Immune Trombocytopenia. American Journal of Medical Case Reports. 2015;3(9):301-303 doi:10.12691/ajmcr-3-9-10
A116. Kaya E, Erkurt MA, Berber I, Köroğlu M, Kuku I. Double-Hit Lymphoma Presenting with Aggressive Progression: A Case Report. J Turgut Ozal Med Cent 2013:20(1):74- 76
A117. Nizam I, Erkurt MA, Kaya E, Kuku I, Koroglu M. Aggressive Progression of Mantle Cell Lymphoma: A Case Report. American Journal of Medical Case Reports. 2014;2(1):30-31. doi:10.12691/ajmcr-2-1-10
A118. Sarıcı A, Erkurt MA, Kuku I, Gök S, Bahçecioğlu ÖF, Biçim S, Berber I, Kaya E, Özgül M. FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome. Medical Science and Discovery, 8(6), 356-360. doi:10.36472/msd.v8i6.545
A119. Erkurt MA, Hindilerden F, Ekinci O, Yildiz J, Dal MS, Bagci M, Hacibekiroglu T, Dogu MH, Namdaroglu S, Basturk A, Gulturk E, Merter M, Saglam B,Demircioglu S, Ozatli D, Sarici A, Ulas T, Korkmaz S, Eser B, Altuntas F. An Experience on Pomalidomide in Patients within Relapsed/Refractory Multiple Myeloma - A Multicenter Study in Turkey. Journal of Pharmaceutical Research International. 2021 June; 32(41): 92-98 doi:10.9734/jpri/2020/v32i4131047
A120. Sarici A, Erkurt MA, Kuku I, Bahcecioglu OF, Gok S, Bicim S, Berber I, Kaya E. Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfancyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation. Medicine Science 2021;10(4):1133-7. doi: 10.5455/medscience.2021.03.083
A121. Deviren M V, Sarici A, Erkurt M A, Bahcecioglu O F, Bicim S, Berber I., ... & KukuI (2021). BK virus incidence, risk factors and its effect on mortality in hematopoietic stem cell transplant patients-single center experience. Medicine 10(3), 856-9. doi:
10.5455/medscience.2021.02.040
A122. Sarıcı A, Kaya E, Erkurt MA, Berber I, Tanrıverdi LH, Bahcecioglu OF, Gok S, Kuku I. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure . Ann Med Res
2021;28(10):1824-9 doi: 10.5455/annalsmedres.2021.01.098
A123. Berber I, Cagin YF, Erdogan MA, Ataman E, Gozukara H, Erkurt MA, ... & Polat A. Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis. Transfusion and Apheresis Science, 2021;60(5), 103250. doi:
10.1016/j.transci.2021.103250
A124. Sarıcı A, Erkurt MA, Kuku İ, Bahçecioğlu ÖF, Biçim S, Kaya E, ... & Özgül M. The effect of comorbidity on survival and collected CD34+ cell counts in autologous hematopoietic stem cell transplant patients. Transfusion and Apheresis Science.
Oct,2021 doi: doi: 10.1016/j.transci.2021.103296
A125. Vural A., Berber İ., Sarıcı A., Erkurt MA., Kaya E., Kuku İ. Long-Term Follow-up Results of Newly Diagnosed, Untreated Adult Primary Immune Thrombocytopenia Patients in Turkey. Acta Medica Mediterranea. 2021, 37: 3075 DOI: 10.19193/0393-
6384_2021_6_482
A126. Sarıcı A., Erkurt MA., Bahcecioglu OF., Tanrıverdi LH., Berber I., Kaya E., Bicim S., Gok S., Ozgul M., Kuku I. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center
experience. Ann Med Res 2021;28(11):2065-70 DOI: 10.5455/annalsmedres.2021.03.206
A127. Ögül M, Kuku I, Erkurt MA, Sarıcı A, Biçim S, Berber I, Kaya E, Hidayet E, Kaya A, Uysal A. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions. International Journal of Research and Reports in Hematology
2021;4(2) : 117-122
A128. Sarici A, Erkurt M A, Kuku I, Bicim S, Berber I, Kaya E, & Ozgul M (2021). Life saving effect of early use of convalescent plasma in Covid-19 treatment. Annals of Medical Research, 28(12), 2242-2247. DOI: 10.5455/annalsmedres.2021.03.228
A129. Sarici A, Bicim S, Erkurt MA, Berber I, Kaya E, Kuku I, & Ozgul M. (2021). Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma. Annals of Medical Research, 28(12), 2239-2241.
DOI: 10.5455/annalsmedres.2021.02.191
A130. Karaman S, Sarıcı A, Erkurt MA, Biçim S, Hidayet E, Kaya A, Kuku İ, Yoloğlu S, Berber İ, Kaya E, Özgül M. Non-Infectious Complications in Patients With Allogeneic Hematopoietic Stem Cell Transplantation- Single Center Experience from Eastern
Anatolia. Acta Oncologica Turcica, 2022; 55: xx-xx
A131. Kaya A., Kuku İ., Erkurt M. A., Kaya E., Berber İ., Sarıcı A., ... & Uysal A. Predictive Significance of Mean Platelet Volume and Platelet Distribution Width Level in Immune Thrombocytopenia Patients Treated With Steroids. International Journal of
Research and Reports in Hematology 2022;5(1) ,
A132. Biçim S, Berber İ, Erkurt MA, Kuku İ, Kaya E, Bilgiç Y, Sarıcı A, Kaya A, Hidayet E, Uysal A. The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma. International Journal of Research and
Reports in Hematology. 2022 ; 5(2)
A133. Bayır B, Aylaz R, Erkurt MA, Bostancı S. Psychological well-being in patients undergoing stem cell transplantation. HEALTH SCIENCES 2021; 44 (1807-8648) Doi: 10.4025/actascihealthsci.v44i1.56546
A134. Yildiz J., Bagci M., Sayin S., Kaya A., Yilmaz F., Ekinci O., Dal MS., Basturk A., Aydogdu İ., Albayrak M., Dogan A., Erkurt MA., Korkmaz S., Ulas T., Eser B. & Altuntas, F. (2022). The clinicopathological features and survival of Castlemandisease: a multicenter Turkish study. European Review for Medical and Pharmacological Sciences, 26, 1131-1137.
A135. Cakan P, Ozgul M, Erkut MA, Kaya E, Yildiz S, & Kuku I. Cardiac autonomic control during platelet apheresis. Annals of Medical Research. 2022;29(3):203–210. Doi: https://doi.org/10.5455/annalsmedres.2021.08.532
A136. Uysal A, Erkurt MA, Kuku I, Sarici A, Bicim S, Kaya E, & Berber I. (2022). Convalescent plasma therapy in COVID-19. Medicine, 11(2). doi: 10.5455/medscience.2021.09.292
A137. Hidayet E, Erkurt M. A, Sarici A, Bicim S, Kuku I, Berber I, ... & Uysal A. (2022). Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia. Medicine, 11(2),
762-5. doi: 10.5455/medscience.2021.11.379
A138. Kaya A, Erkurt MA, Kuku İ, Kaya E, Berber İ, Sarıcı A, Biçim S, Hidayet E, Yağın FH. Effects Of Ethnicity On Allogenic Stem Cell Mobilization. International Journal of Clinical Images and Medical Reviews. 2022; 2 (2).
Doi:10.55920/IJCIMR.2022.02.001065
A139. GULBAY G, BAG HG, YESILADA E, & ERKURT MA. (2022). Calreticulin Mutations in Philadelphia Chromosome Negative Myeloproliferative Neoplasms. International Journal of Hematology and Oncology, 32(2), 075-080.
A140. Sarıcı A, Erkurt MA, Kuku İ, Kaya E, Berber İ, Biçim S, ... & Uysal A. (2022). The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers. Transfusion and
Apheresis Science, 103482.
A141. Basturk A, Bagci M, Dal MS, Hacibekiroglu T, Hacioglu SK, Aydogdu I, ... ErkurtMA… & Altuntas F. (2022). PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA.
HemaSphere, 6(Suppl).
A142. Kaya A, Erkurt MA, Kuku İ, Kaya E, Berber İ, Biçim S, ... & Sarıcı A. (2022). The frequency of HLA A, B, C, DP, DQ, DR allele in patients of Turkish and Syrian nationals with allogeneic stem cell transplantation. Iraqi Journal of Hematology, 11(2), 110.
A143. Erkurt MA, Sarici A, Özer AB, Kuku İ, Biçim S, Aydogan MS, ... & Keser MF. (2022). The effect of HA330 hemoperfusion adsorbent method on inflammatory markers and end-organ damage levels in sepsis: a retrospective single center study. Eur Rev Med Pharmacol Sci, 26(21), 8112-8117.
A144. Uysal A, Erkurt MA, Kuku İ, Kaya E, Berber İ, Sarıcı A, ... & Hidayet E. How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience. Acta Oncologica Turcica, 56(2), 0-0.
A145. UYSAL A, ERKURT MA, Irfan KUKU, Emin KAYA, BERBER I, SARICI A, ... & HIDAYET E. (2023). How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-Center Experience. Acta Oncologica Turcica, 56(2), 106-
113.
A146. Özatli D, Odabaşı Giden A, Erkurt MA, Sönmez M, Özet G, Altuntaş F. (2023). International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report, 62(2), 3684-2884. DOI:
https://doi.org/10.1016/j.transci.2023.103662.
A147. Kaya A, Kuku İ, MA Erkurt, Kaya E, Berber İ, Biçimi S, Hidayet E, Cırık S, Arslan S, Yagın FH, Sarıcı A. (2023). The effect of thrombocytapheresis on hemogram and biochemistry parameters in patient with essential thrombocytemia, 3755-8046. DOI:
https://doi.org/10.1016/j.tracli.2023.08.001.
A148. Kaya A, MA Erkurt, Kuku İ, Kaya E, Berber İ, Biçimi S, Hidayet E, Cırık S, Arslan S, Yagın FH, Sarıcı A (2023). Effect of extracorporeal photopheresis on survival in acute graft vrsus host disease, 37421294. DOI: 10.1002/jca.22071.
A149. Biçim, Soykan; Erkurt, Mehmet Ali; Kuku, İrfan; Kaya, Emin; Berber, İlhami; Kaya, Ahmet; Hidayet, Emine1; Uysal, Ayşe2; Sarıcı, Ahmet3; Özen, İlknur Nizam4. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen
for autologous stem cell transplantation in Hodgkin’s lymphoma patients. Iraqi Journal of Hematology ():10.4103/ijh.ijh_88_23, January 18, 2024. | DOI: 10.4103/ijh.ijh_88_23
A150. Kaya, A., Berber, İ., Kuku, İ., Kaya, E., Erkurt, M. A., Biçim, S., ... & Yağin, F. H. (2024). Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and
engraftment time?. Iraqi Journal of Hematology, 10-4103.
A151. Çelik, S., Erkurt, M. A., Sarıcı, A., Kuku, İ., Kaya, E., Berber, İ., & Yıldız, S. (2024). The role of therapeutic plasma exchange in the treatment of patients with septic shock-single center experience. Journal of Current Hematology & Oncology
Research, 2(3), 67-71.
A152. Cirik, S., Erkurt, M. A., Kuku, İ., Kaya, E., Berber, İ., Hidayet, E., ... & Günay, A. (2024). Concurrent congenital hemophilia B and acquired hemophilia A: a unique case report. Blood Coagulation & Fibrinolysis, 35(5), 282-285.
A153. Eryıldız Yücel, S., Kuku, İ., Kaya, E., Erkurt, M. A., & Berber, İ. (2024). Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center. Journal of Current Hematology & Oncology Research, 2(2), 28-32.
A154. Namdaroglu, S., Hidayet, E., Aydin, M. S., Erkurt, M. A., Berber, I., Cinar, O. E., ... & Altuntas, F. (2024). The role of ruxolitinib in the management of acute GVHD. Transfusion and Apheresis Science, 104055.
A155. Erkurt, M. A., Sarici, A., Sahin, A., Berber, I., Korkmaz, G., Kuku, I., ... & Altuntas, F. (2024). Effectiveness of ibrutinib in the management of chronic GVHD. Transfusion and Apheresis Science, 104052.
A156. Yigenoglu, T. N., Erkurt, M. A., Dagdas, S., Ulu, B. U., Kuku, I., Durdu, A., ... & Altuntas, F. (2024). What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?. Transfusion and Apheresis Science, 104057.
A157. Yigenoglu, T. N., Ulu, B. U., Namdaroglu, S., Erkurt, M. A., Sahin, R., Okumus, N., ... & Altuntas, F. (2024). Is there a relationship between vitamin D levels and graft versus host disease?. Transfusion and Apheresis Science, 104054.
A158. Ulas, T., Namdaroglu, S., Hindilerden, I. Y., Erkurt, M. A., Erer, K., Yigenoglu, T. N., ... & Altuntas, F. (2024). What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?. Transfusion and Apheresis Science, 104058.
A159. Karakus, A., Toptas, T., Dal, M. S., Durdu, A., Hatipoglu, U., Kayer, M. A., ... &Altuntas, F. (2025). Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias. Bone Marrow Transplantation, 1-9.
A160. Giden, A. O., Erkurt, M. A., Hindilerden, I. Y., Hidayet, E., Berber, I., Tiryaki, T. O., ... & Altuntas, F. (2025). Efficacy of Ruxolitinib in the management of chronic GVHD. Transfusion and Apheresis Science, 64(1), 104053
A161. Arslan, S., Berber, I., Kuku, I., Kaya, E., Erkurt, M. A., Biçim, S., ... & Pinar, A. (2025). When should I use filgrastim after autologous transplantation in MM patients?. Transfusion and Apheresis Science, 64(4), 104171.
A162. Batgi, H., Zorlu, T., Erkurt, M. A., Uzay, A., Hindilerden, I. Y., Pepeler, M. S., ... & Altuntas, F. (2025). The Impact of Second Allogeneic Hematopoietic Stem Cell Transplantation as Salvage Therapy for Hematologic Diseases After a First Allogeneic Transplantation. Transfusion and Apheresis Science, 104187.
A163. Aslan Candir B, Okumus N, Hindilerden IY, Erkurt MA, Namdaroglu S, Merter M, Yilmaz S, Koroglu M, Zorlu T, Tiryaki TO, Katircilar Y, Uzay A, Seyhan M, Ozbalak MM, Dal MS, Ulaş T, Korkmaz S, Altuntas F. The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes. Transfus Apher Sci. 2025 Jun 20;64(4):104186. doi: 10.1016/j.transci.2025.104186. Epub ahead of print. PMID: 40555163.
A164. Sarici A, Erkurt MA, Yilmaz S, Demircioglu S, Berber I, Basturk A, Merter M, Kuku I, Koroglu M, Kaya E, Dal MS, Korkmaz S, Ulaş T, Altuntas F. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma. Transfus Apher Sci. 2025 Jun 20;64(4):104185. doi: 10.1016/j.transci.2025.104185. Epub ahead of print. PMID: 40570804.
A165. Erkurt MA, Yilmaz S, Namdaroglu S, Demircioglu S, Sarici A, Cirik S, Koroglu M, Merter M, Basci S, Berber I, Basturk A, Dal MS, Ulaş T, Korkmaz S, Altuntas F. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes? Transfus Apher Sci. 2025 Jun 20;64(4):104184. doi: 10.1016/j.transci.2025.104184. Epub ahead of print. PMID: 40570803.
A166. Yılmaz LZB, Memişoğlu F, Hidayet E, Kuku İ, Erkurt MA, Kaya E, Berber İ. Cytomegalovirus Infection Risk Factors in Allogeneic Hematopoietic Stem Cell Transplantation Can Defibrotide Be a Risk Factor? Transplant Proc. 2025 Jun 27:S0041-1345(25)00281-7. doi: 10.1016/j.transproceed.2025.05.018. Epub ahead of print. PMID: 40581568.
A167. Yilmaz S, Okumus N, Seyhan M, Sahin R, Korkmaz G, Erkurt MA, Namdaroglu S, Cirik S, Demircioglu S, Uzay A, Sahin A, Koroglu M, Hatipoglu U, Dal MS, Ulaş T, Korkmaz S, Altuntas F. Does body mass index affect stem cell yield in healthy donors? Transfus Apher Sci. 2025 Jun 20;64(4):104181. doi: 10.1016/j.transci.2025.104181. Epub ahead of print. PMID: 40609366.
A168. Karakus A, Hatipoglu U, Katircilar Y, Erkurt MA, Yilmaz S, Cagliyan GA, Ozturk F, Hidayet E, Demircioglu S, Koroglu M, Uzay A, Basturk A, Karti SS, Sarici A, Unal S, Dal MS, Ulaş T, Korkmaz S, Altuntas F. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma. Transfus Apher Sci. 2025 Jun 26;64(4):104183. doi: 10.1016/j.transci.2025.104183. Epub ahead of print. PMID: 40627978.
A169. Katircilar Y, Sahin A, Aydin MS, Erer K, Erkurt MA, Namdaroglu S, Yilmaz S, Demircioglu S, Uzay A, Durdu A, Koroglu M, Ozet G, Apaydin M, Dal MS, Ulas T, Korkmaz S, Altuntas F. Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type? Transfus Apher Sci. 2025 Jun 20;64(4):104182. doi: 10.1016/j.transci.2025.104182. Epub ahead of print. PMID: 40627979.
A170. Bakirtas, M., Hindilerden, I. Y., Ulu, B. U., Ekinci, O., Dogu, M. H., Aydogdu, I., ... & Erkurt M.A., Dal M.S., Korkmaz S., Ulas T., Altuntas, F. (2025). Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety. Indian Journal of Hematology and Blood Transfusion, 1-11. https://doi.org/10.1007/s12288-025-02093-w
A171. Sarıcı, A., Berktas, H. B., Erkurt, M. A., & Tanrıverdi, L. H. (2025). MPN-223: Hope or hazard? The safety profile of Roxadustat in patients with anemia. Clinical Lymphoma Myeloma & Leukemia, 25, S653. https://doi.org/10.1016/s2152-2650(25)02100-7
A172. Arslan, S., Kuku, I. F., Kaya, E., Erkurt, M. A., Berber, I., Bozdag, Z., Özcan, M., & Sarıcı, A. (2025). TCL-367: a case of T-PLL refractory to multiple treatments. Clinical Lymphoma Myeloma & Leukemia, 25, S863. https://doi.org/10.1016/s2152-2650(25)02495-4
A173. Bakırtas, M., Berber, I., Hindilerden, I. Y., Dal, M. S., Güner, S. I., Uysal, A., Ekinci, Ö., Candır, B. A., Eser, B., Akpınar, S., Biçim, S., Yigenoglu, T. N., Ulas, T., Turgut, B., Erkurt, M. A., & Altuntas, F. (2025b). CT-375: Real-World Efficacy and Safety of Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A Multicenter Retrospective Study from Turkey. Clinical Lymphoma Myeloma & Leukemia, 25, S1015. https://doi.org/10.1016/s2152-2650(25)02779-x
A174. ARSLAN, S., Berber, İ., Kuku, İ., Kaya, E., Erkurt, M. A., Sarıcı, A., & Özcan, M. (2025). A RARE DIAGNOSIS IN ADULTS: HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA. Hematology, Transfusion and Cell Therapy, 47, 106147. https://doi.org/10.1016/j.htct.2025.106147
A175. Karakus A, Toptas T, Dal MS, Durdu A, Hatipoglu U, Kayer MA, Hindilerden IY, Tiryaki TO, Iskender D, Ulu BU, Yigenoglu TN, Erkurt MA, Ulas T, Altuntas F. Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias. Bone Marrow Transplant. 2025 Jun;60(6):864-872. doi: 10.1038/s41409-025-02564-8. Epub 2025 Apr 13. PMID: 40223010; PMCID: PMC12151847.
A176. Uzun, A., Kuku, İ., Kaya, E., & Erkurt, M. A. (2025). Etiologic evaluation of male patients diagnosed with anemia in the first consultation of the hematology department. Journal of Current Hematology & Oncology Research, 3(1), 11-14. DOI: 10.51271/JCHOR-0053
A177. Yigenoglu, T. N., Erkurt, M. A., Dagdas, S., Ulu, B. U., Kuku, I., Durdu, A., ... & Altuntas, F. (2025). What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?. Transfusion and Apheresis Science, 64(1), 104057. https://doi.org/10.1016/j.transci.2024.104057
A178. Seçilmiş, S., Kabukçu Hacıoğlu, S., Hindilerden, F., Turgut, B., Özatlı, D., Akgün Çağlıyan, G., Baştürk, A., Yüksel Öztürkmen, A., Katırcılar, Y., Namdaroğlu, S., Ünver Koluman, B., Sunu, C., Korkmaz, S., Uysal, A., Bilen, Y., Erkurt, M. A., Dal, M. S., Ulaş, T., & Altuntaş, F. (2026). Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study. Journal of Clinical Medicine, 15(2), 854. https://doi.org/10.3390/jcm15020854
A179. Bakırtaş, M., Berber, İ., Hindilerden, İ. Y., Dal, M. S., İzmir Güner, Ş., Uysal, A., Ekinci, Ö., Aslan Candır, B., Eser, B., Akpınar, S., Biçim, S., Yiğenoğlu, T. N., Ulaş, T., Turgut, B., Erkurt, M. A., & Altuntaş, F. (2026). Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey. Journal of Clinical Medicine, 15(5), 2088. https://doi.org/10.3390/jcm15052088
A180. Sarıcı, A., Erkurt, M. A., Kaya, E., Kuku, İ., Berber, İ., Arslan, S., Deniz, B., Çiçek, İ. B., & Hidayet, E. (2026). The Effect of Nutritional Support on Malnutrition and Muscle Loss in Hematological Cancer Patients: A Retrospective Single-center Study. Acta Haematologica Oncologica Turcica, 59(1), 48-55. https://doi.org/10.4274/ahot.galenos.2026.2026-2-7